{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:06:13Z","timestamp":1791237973274,"version":"4.1.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771783"],"award-info":[{"award-number":["81771783"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073444"],"award-info":[{"award-number":["82073444"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.abd.2021.10.007","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T08:25:06Z","timestamp":1657873506000},"page":"612-623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["The risk of organ-based comorbidities in psoriasis: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6844-3188","authenticated-orcid":false,"given":"Xuemei","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1485-1626","authenticated-orcid":false,"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2021.10.007_bib0005","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.abd.2021.10.007_bib0010","doi-asserted-by":"crossref","first-page":"16082","DOI":"10.1038\/nrdp.2016.82","article-title":"Psoriasis","volume":"2","author":"Greb","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.abd.2021.10.007_bib0015","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.abd.2021.10.007_bib0020","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cyto.2018.08.025","article-title":"Differential efficacy of biologic treatments targeting the TNF-\u03b1\/IL-23\/IL-17 axis in psoriasis and psoriatic arthritis","volume":"111","author":"Furue","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.abd.2021.10.007_bib0025","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1468-3083.2012.04531.x","article-title":"Psoriasis prevalence among the 2009 AAD National Melanoma\/Skin Cancer Screening Program participants","volume":"27","author":"Lima","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2021.10.007_bib0030","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/jid.2012.434","article-title":"Psoriasis epidemiology: the interplay of genes and the environment","volume":"133","author":"Enamandram","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2021.10.007_bib0035","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/jech.57.10.778","article-title":"Life course epidemiology","volume":"57","author":"Kuh","year":"2003","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.abd.2021.10.007_bib0040","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team. Global epidemiology of psoriasis: a systematic review of incidence and prevalence","volume":"133","author":"Parisi","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2021.10.007_bib0045","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3389\/fimmu.2018.01549","article-title":"The Interplay Between Keratinocytes and Immune Cells in the Pathogenesis of Psoriasis","volume":"9","author":"Albanesi","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.abd.2021.10.007_bib0050","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","article-title":"Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells","volume":"128","author":"Lowes","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2021.10.007_bib0055","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/jid.2012.434","article-title":"Psoriasis epidemiology: the interplayof genes and the environment","volume":"133","author":"Enamandram","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2021.10.007_bib0060","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/jid.2010.103","article-title":"Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions","volume":"130","author":"Davidovici","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2021.10.007_bib0065","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and comorbid diseases: Epidemiology","volume":"76","author":"Takeshita","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2021.10.007_bib0070","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/abd1806-4841.20153038","article-title":"Psoriasis: classical and emerging comorbidities","volume":"90","author":"Oliveira","year":"2015","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.abd.2021.10.007_bib0075","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jaad.2016.07.065","article-title":"Psoriasis and comorbid diseases: Implications for management","volume":"76","author":"Takeshita","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2021.10.007_bib0080","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jamadermatol.2013.5015","article-title":"Psoriasis severity and the prevalence of major medical comorbidity: a population-based study","volume":"149","author":"Yeung","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.abd.2021.10.007_bib0085","doi-asserted-by":"crossref","first-page":"528","DOI":"10.5694\/mja2.50591","article-title":"Beyond skin deep: addressing comorbidities in psoriasis","volume":"212","author":"Kovitwanichkanont","year":"2020","journal-title":"Med J Aust"},{"key":"10.1016\/j.abd.2021.10.007_bib0090","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.abd.2021.10.007_bib0095","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.3389\/fimmu.2018.01390","article-title":"T-Cell Hierarchy in the Pathogenesis of Psoriasis and Associated Cardiovascular Comorbidities","volume":"9","author":"Casciano","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.abd.2021.10.007_bib0100","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2340\/00015555-0770","article-title":"Comorbidity, and age-related prevalence of psoriasis: Analysis of health insurance data in Germany","volume":"90","author":"Augustin","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.abd.2021.10.007_bib0105","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/jdv.12847","article-title":"Risk of non-alcoholic fatty liver disease in psoriatic patients: a systematic review and meta-analysis","volume":"29","author":"Candia","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2021.10.007_bib0110","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00403-011-1200-6","article-title":"Psoriasis increased the risk of diabetes: a meta-analysis","volume":"304","author":"Cheng","year":"2012","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.abd.2021.10.007_bib0115","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1080\/09546634.2016.1255703","article-title":"Psoriasis increases risk of new-onset atrial fibrillation: a systematic review and meta-analysis of prospective observational studies","volume":"28","author":"Upala","year":"2017","journal-title":"Journal of Dermatolog Treat"},{"key":"10.1016\/j.abd.2021.10.007_bib0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145221","article-title":"Association between Psoriasis and Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.abd.2021.10.007_bib0125","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.abd.2021.10.007_bib0130","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000015370","article-title":"Increased risk of migraine in psoriatic patients: A longitudinal follow up study using a national sample cohort","volume":"98","author":"Min","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.abd.2021.10.007_bib0135","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1365-2133.2011.10494.x","article-title":"Medical comorbidity associated with psoriasis in adults: a population-based study","volume":"165","author":"Yang","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2021.10.007_bib0140","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1001\/jamadermatol.2017.5417","article-title":"Association of Psoriasis With Comorbidity Development in Children With Psoriasis","volume":"154","author":"Tollefson","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.abd.2021.10.007_bib0145","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jchf.2019.11.013","article-title":"Differential Associations of Chronic Inflammatory Diseases With Incident Heart Failure","volume":"8","author":"Prasada","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.abd.2021.10.007_bib0150","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2796.2011.02368.x","article-title":"Prognosis following first-time myocardial infarction in psoriatic patients: a Danish nationwide cohort study","volume":"270","author":"Ahlehoff","year":"2011","journal-title":"J Intern Med"},{"key":"10.1016\/j.abd.2021.10.007_bib0155","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1093\/eurheartj\/ehr285","article-title":"Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study","volume":"33","author":"Ahlehoff","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.abd.2021.10.007_bib0160","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00403-013-1419-5","article-title":"Psoriasis, electrocardiographic characteristics, and incidence of atrial fibrillation","volume":"305","author":"Armstrong","year":"2013","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.abd.2021.10.007_bib0165","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/rheumatology\/key286","article-title":"Risk of type 2 diabetes and cardiovascular disease in an incident cohort of people with psoriatic arthritis: a population-based cohort study","volume":"58","author":"Charlton","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.abd.2021.10.007_bib0170","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1346-8138.2011.01401.x","article-title":"Psoriasis and increased risk of ischemic stroke in Taiwan: a nationwide study","volume":"39","author":"Chiang","year":"2012","journal-title":"J Dermatol"},{"key":"10.1016\/j.abd.2021.10.007_bib0175","first-page":"874","article-title":"Economic and Comorbidity Burden Among Patients with Moderate-to-Severe Psoriasis","volume":"21","author":"Feldman","year":"2015","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.abd.2021.10.007_bib0180","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/eurheartj\/ehv185","article-title":"Increased risk of aortic valve stenosis in psoriatic patients: a nationwide cohort study","volume":"36","author":"Khalid","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.abd.2021.10.007_bib0185","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1080\/13696998.2018.1431921","article-title":"Comorbidity and economic burden among moderate-to-severe psoriasis and\/or psoriatic arthritis patients in the US Department of Defense population","volume":"21","author":"Lee","year":"2018","journal-title":"J Med Econ"},{"key":"10.1016\/j.abd.2021.10.007_bib0190","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1684\/ejd.2015.2525","article-title":"Restless legs syndrome in psoriasis: an unexpected comorbidity","volume":"25","author":"Schell","year":"2015","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.abd.2021.10.007_bib0195","first-page":"593","article-title":"Incidence of psoriasis and association with comorbidities in Italy: a 5-year observational study from a national primary care database","volume":"20","author":"Vena","year":"2010","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.abd.2021.10.007_bib0200","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jamadermatol.2013.5015","article-title":"Psoriasis severityand the prevalence of major medical comorbidity: a population-based study","volume":"149","author":"Yeung","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.abd.2021.10.007_bib0205","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.3390\/jcm9093004","article-title":"Psoriasis and Its Impact on In-Hospital Outcome in Patients Hospitalized with Acute Kidney Injury","volume":"9","author":"Wild","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.abd.2021.10.007_bib0210","first-page":"438","article-title":"Chronic kidney disease in psoriasis: a cohort study","volume":"18","author":"Conti","year":"2020","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.abd.2021.10.007_bib0215","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.1111\/1346-8138.14784","article-title":"Case of psoriasis vulgaris with atrial fibrillation, heart failure and chronic kidney disease which were found accidentally through blood examination during apremilast treatment","volume":"46","author":"Tokuyama","year":"2019","journal-title":"J Dermatol"},{"key":"10.1016\/j.abd.2021.10.007_bib0220","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/jdv.15290","article-title":"Association between psoriasis, psoriatic arthritis and gout: a nationwide population-based study","volume":"33","author":"Hu","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2021.10.007_bib0225","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3899\/jrheum.170384","article-title":"Characteristic and Outcome of Psoriatic Arthritis Patients with Hyperuricemia","volume":"45","author":"AlJohani","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1016\/j.abd.2021.10.007_bib0230","doi-asserted-by":"crossref","first-page":"e304","DOI":"10.1111\/ajd.13098","article-title":"Nonalcoholic fatty liver disease puts psoriatic patients at greater cardiovascular risk","volume":"60","author":"Romero-P\u00e9rez","year":"2019","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.abd.2021.10.007_bib0235","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/HJH.0b013e32835bcce1","article-title":"The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies","volume":"31","author":"Armstrong","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.abd.2021.10.007_bib0240","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s11255-018-1868-z","article-title":"Psoriasis and risk of incident chronic kidney disease and end-stage renal disease: a systematic review and meta-analysis","volume":"50","author":"Ungprasert","year":"2018","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.abd.2021.10.007_bib0245","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1161\/STROKEAHA.115.012052","article-title":"Cerebrovascular Disease in Rheumatic Diseases: A Systematic Review and Meta-Analysis","volume":"47","author":"Wiseman","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.abd.2021.10.007_bib0250","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.3389\/fimmu.2019.03096","article-title":"IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications","volume":"10","author":"Stebut","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.abd.2021.10.007_bib0255","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jaad.2013.09.020","article-title":"From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies","volume":"70","author":"Hugh","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2021.10.007_bib0260","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.3389\/fimmu.2018.01323","article-title":"The Interleukin-23\/Interleukin-17 Axis Links Adaptive and Innate Immunity in Psoriasis","volume":"9","author":"Sch\u00f6n","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.abd.2021.10.007_bib0265","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12016-018-8702-3","article-title":"The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis","volume":"55","author":"Blauvelt","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.abd.2021.10.007_bib0270","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/nbt1216-1218","article-title":"New anti-IL-23 drugs raise hopes for psoriasis plaque clearance","volume":"34","author":"Dolgin","year":"2016","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.abd.2021.10.007_bib0275","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1080\/17425255.2019.1681969","article-title":"Pharmacodynamics OF TNF \u03b1 inhibitors for the treatment of psoriasis","volume":"15","author":"Campanati","year":"2019","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.abd.2021.10.007_bib0280","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pharmthera.2007.10.001","article-title":"Tumor necrosis factor antagonist mechanisms of action: a comprehensive review","volume":"117","author":"Tracey","year":"2008","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.abd.2021.10.007_bib0285","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/bjd.18245","article-title":"Management of psoriasis as a systemic disease: what is the evidence?","volume":"182","author":"Korman","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2021.10.007_bib0290","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jaad.2018.02.040","article-title":"Interleukin 17, inflammation, and cardiovascular risk in psoriatic patients","volume":"79","author":"Lockshin","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2021.10.007_bib0295","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fphar.2020.00117","article-title":"Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities","volume":"11","author":"Gisondi","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.abd.2021.10.007_bib0300","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000062","article-title":"Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies","volume":"2","author":"Armstrong","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.abd.2021.10.007_bib0305","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00403-016-1712-1","article-title":"Psoriasis and cardiovascular events: updating the evidence","volume":"309","author":"Raaby","year":"2017","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.abd.2021.10.007_bib0310","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/00063030-200317030-00005","article-title":"Role of novel biological therapies in psoriatic arthritis: effects on joints and skin","volume":"17","author":"Braun","year":"2003","journal-title":"BioDrugs"},{"key":"10.1016\/j.abd.2021.10.007_bib0315","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s10067-017-3537-5","article-title":"Impact of treatment with TNF antagonists on total cholesterol in patients with ankylosing spondylitis and psoriatic arthritis","volume":"36","author":"Maneiro","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.abd.2021.10.007_bib0320","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1080\/1744666X.2020.1685382","article-title":"TNF-alpha inhibitors for the six treatment targets of psoriatic arthritis","volume":"15","author":"Lubrano","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.abd.2021.10.007_bib0325","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/515136","article-title":"Cytokines in the Progression of Pancreatic \u03b2-Cell Dysfunction","volume":"2010","author":"Wang","year":"2010","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.abd.2021.10.007_bib0330","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jaut.2016.02.001","article-title":"Life and death of \u03b2 cells in Type 1 diabetes: A comprehensive review","volume":"71","author":"Wilcox","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.abd.2021.10.007_bib0335","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/jdv.16273","article-title":"The role of the interleukin-23\/Th17 pathway in cardiometabolic comorbidity associated with psoriasis","volume":"34","author":"Egeberg","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2021.10.007_bib0340","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.3389\/fimmu.2018.01682","article-title":"The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond","volume":"9","author":"Brembilla","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.abd.2021.10.007_bib0345","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.it.2012.11.005","article-title":"The IL-23\/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses","volume":"34","author":"Lowes","year":"2013","journal-title":"Trends Immunol"},{"key":"10.1016\/j.abd.2021.10.007_bib0350","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/jdv.16073","article-title":"Adverse events with IL-17 and IL-23 inhibitors for psoriasis and psoriatic arthritis: a systematic review and meta-analysis of phase III studies","volume":"34","author":"Loft","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2021.10.007_bib0355","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s40257-018-0366-5","article-title":"Targeting the IL-23\/IL-17 Pathway in Psoriasis: the Search for the Good, the Bad and the Ugly","volume":"19","author":"Mylle","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.abd.2021.10.007_bib0360","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/jdv.14868","article-title":"Shifting the focus - the primary role of IL-23 in psoriasis and other inflammatory disorders","volume":"32","author":"Gooderham","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2021.10.007_bib0365","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jaci.2017.07.004","article-title":"Psoriasis pathogenesis and the development of novel targeted immune therapies","volume":"140","author":"Hawkes","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.abd.2021.10.007_bib0370","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-med-042915-103905","article-title":"Highly Effective New Treatments for Psoriasis Target the IL-23\/Type 17 T Cell Autoimmune Axis","volume":"68","author":"Kim","year":"2017","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.abd.2021.10.007_bib0375","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s40257-015-0162-4","article-title":"Anti-IL-17 Medications Used in the Treatment of Plaque Psoriasis and Psoriatic Arthritis: A Comprehensive Review","volume":"17","author":"Canavan","year":"2016","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.abd.2021.10.007_bib0380","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jaad.2020.07.085","article-title":"Efficacy of a second interleukin 17 inhibitor in psoriatic patients: A systematic review and meta-analysis","volume":"84","author":"Loft","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2021.10.007_bib0385","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jaad.2013.12.036","article-title":"Interleukin 17A: toward a new understanding of psoriasis pathogenesis","volume":"71","author":"Lynde","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2021.10.007_bib0390","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12016-018-8668-1","article-title":"Psoriasis: from Pathogenesis to Targeted Therapies","volume":"54","author":"Conrad","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.abd.2021.10.007_bib0395","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12016-017-8634-3","article-title":"Unmet Needs in the Field of Psoriasis: Pathogenesis and Treatment","volume":"55","author":"Boehncke","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.abd.2021.10.007_bib0400","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jaad.2018.06.057","article-title":"Psoriasis: Which therapy for which patient: Psoriasis comorbidities and preferred systemic agents","volume":"80","author":"Kaushik","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2021.10.007_bib0405","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1111\/jdv.15177","article-title":"Position statement for the management of comorbidities in psoriasis","volume":"32","author":"Dauden","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2021.10.007_bib0410","doi-asserted-by":"crossref","first-page":"b5666","DOI":"10.1136\/bmj.b5666","article-title":"Managing comorbid disease in psoriatic patients","volume":"340","author":"Boehncke","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.abd.2021.10.007_bib0415","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jaad.2018.06.056","article-title":"Psoriasis: Which therapy for which patient: Focus on special populations and chronic infections","volume":"80","author":"Kaushik","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2021.10.007_bib0420","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.3899\/jrheum.141112","article-title":"Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative","volume":"42","author":"Roubille","year":"2015","journal-title":"J Rheumatol"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059622001374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059622001374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T23:41:09Z","timestamp":1759794069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059622001374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":84,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0365059622001374"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2021.10.007","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The risk of organ-based comorbidities in psoriasis: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2021.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}